The role of human epididymis protein 4 as a biomarker in gynecologic malignancies
| العنوان: | The role of human epididymis protein 4 as a biomarker in gynecologic malignancies |
|---|---|
| المؤلفون: | Francesco Plotti, Roberto Angioli, Giuseppe Scaletta, Gianmarco Rossini, Roberto Montera, Michele Moncelli, Corrado Terranova, Teresa Schirò, Daniela Luvero, Alessandra Gatti, Federica Guzzo, Carlo De Cicco Nardone |
| المصدر: | Minerva Ginecologica. 71 |
| بيانات النشر: | Edizioni Minerva Medica, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Oncology, medicine.medical_specialty, Genital Neoplasms, Female, Carcinoma, Ovarian Epithelial, Sensitivity and Specificity, Diagnosis, Differential, 03 medical and health sciences, WAP Four-Disulfide Core Domain Protein 2, 0302 clinical medicine, Internal medicine, Biomarkers, Tumor, Carcinoma, medicine, Humans, Tumor marker, Ovarian Neoplasms, 030219 obstetrics & reproductive medicine, business.industry, Endometrial cancer, Proteins, Obstetrics and Gynecology, Histology, medicine.disease, Epididymis, Endometrial Neoplasms, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Ovarian cancer, business, Evidence synthesis |
| الوصف: | Introduction The serum levels of glycoprotein human epididymis protein 4 (HE4) have been widely investigated in patients with ovarian cancer as a tumor marker to differentiate benign gynecological tumors from ovarian cancers (OC). A few studies demonstrated the promising role of HE4 in endometrial cancer (EC) too. The aim of this review is to provide an outline of published studies investigating HE4 in the diagnosis of gynecologic malignancies, focusing on its role in OC and EC. Evidence acquisition We conducted a systematic review of literature from January 1952 to June 2018 on the role of HE4 in OC and EC focusing on the diagnostic power in terms of sensitivity and specificity. Evidence synthesis We identified 49 articles with an overall sample size of 12,631 patients in OC group and five studies with an overall sample size of 1221 patients in EC group. We stated that HE4 had a pooled sensitivity of 78% and specificity of 86% in the detection of borderline or malignant OC and a pooled sensitivity of 78.8% and specificity of 100% in EC diagnosis. Conclusions This systematic review confirms the importance of HE4 in the diagnosis of epithelial ovarian cancer and its promising role in endometrial cancer (endometrioid histology). |
| تدمد: | 1827-1650 0026-4784 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4729d58b1e29f2f1b43ede6e7ebccee https://doi.org/10.23736/s0026-4784.18.04328-9 |
| رقم الأكسشن: | edsair.doi.dedup.....e4729d58b1e29f2f1b43ede6e7ebccee |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 18271650 00264784 |
|---|